NORTHFIELD’S Royal Orthopaedic Hospital is teaming up with MICA Biosystems, a Birmingham-based biotechnology company, to delve into the realm of biomagnetic technology.
This partnership seeks to develop remote-controlled cell technology in orthopaedic medicine and beyond, offering new hope to patients with conditions such as arthritis, osteoporosis, and spinal issues.
This technology operates by remotely issuing instructions to individual cells within the body, enabling their external control through a magnetic field.
Researchers at the hospital’s Dubrowksy Regenerative Medicine Laboratory are diligently investigating this cutting-edge technology using donated patient samples to prepare for upcoming clinical trials at the end of the year.
Prof Adrian Gardner, the Royal Orthopaedic Hospital’s consultant spine surgeon and director of research and development, said: “We’re thrilled to be working with MICA Biosystems on their pioneering research which has the potential to improve patient outcomes, in orthopaedics and beyond.
“We work closely with world-leading industry partners to ensure our patients have access to the very latest innovations in orthopaedic care and it’s brilliant to be collaborating with MICA who are also based in Birmingham – it’s a testament to just how much innovation is taking place right here in the Midlands.”
The Dubrowsky Laboratory, made possible by a generous legacy donation of £1.5million to the Royal Orthopaedic Hospital. Since its opening in 2019, the laboratory has been at the forefront of exploring treatments for rare bone cancers and addressing orthopaedic challenges.
Dr Michal Zurawski, Chief Executive Officer at MICA Biosystems, said: “Our nanotech-augmented, remote-controlled cells have the possibility to change the face of medicine, improving the lives of millions of patients.
“The ability to collaborate with world-class, research-minded clinicians was an important factor in our decision to make Birmingham our home, and the centre of our strategy to bring medicine into the future.”
